Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ImmunoPET Imaging With 89Zr-MPDL3280A in Patients With Locally Advanced or Metastatic Solid Tumors Prior to and During MPDL3280A Treatment

NCT02453984 is registered in ClinicalTrials.gov with University Medical Center Groningen as lead sponsor.

NCT NCT02453984
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02453984 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ImmunoPET Imaging With 89Zr-MPDL3280A in Patients With Locally Advanced or Metastatic Solid Tumors Prior to and During MPDL3280A Treatment
Lead sponsor
University Medical Center Groningen
Phase
Not applicable
Overall status
Unknown status
Start date
February 24, 2016
Completion date
June 30, 2024
Enrollment
45 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

locally advanced or metastatic solid tumors irrespective of pd-l1 expression